Article Figures & Data
Tables
- Table 1.
Sociodemographics and risk factors for study population (n, %)
HPV16 (n = 621) HPV18 (n = 94) Total (n = 1,781) HPV Positive (n = 1,069) Single infection (n = 424) Multiple infection (n = 197) P Single infection (n = 44) Multiple infection (n = 50) P Age, mean (range) 48.2 (20–75) 48.1 (20–75) 47.1 (23–69) 48.5 (27–75) 49.5 (31–68) 48.4 (25–67) <30 56 (3.1) 41 (3.8) 17 (4.0) 3 (1.5) 0.100 0 (0.0) 2 (4.0) 0.598 30 ∼ 39 249 (14.0) 166 (15.5) 71 (16.7) 35 (17.8) 5 (11.4) 5 (10.0) 40 ∼ 49 674 (37.8) 371 (34.7) 159 (37.5) 71 (36.0) 15 (34.1) 21 (42.0) 50 ∼ 59 569 (31.9) 341 (31.9) 135 (31.8) 56 (28.4) 19 (43.2) 18 (36.0) ≥60 233 (13.1) 150 (14.0) 42 (9.9) 32 (16.2) 5 (11.4) 4 (8.0) Marital status Married/cohabitation 1,764 (99.0) 1,055 (98.7) 416 (98.1) 193 (98.0) 0.904 44 (100.0) 50 (100.0) —– Divorced/widowed 17 (1.0) 14 (1.3) 8 (1.9) 4 (2.0) 0 (0.0) 0 (0.0) Smoking No 1,737 (97.5) 1,034 (96.7) 402 (94.8) 191 (97.0) 0.203 41 (93.2) 50 (100.0) 0.061 Yes 44 (2.5) 35 (3.3) 20 (4.7) 4 (2.0) 3 (6.8) 0 (0.0) Drinking No 1,430 (80.3) 797 (74.6) 330 (77.8) 144 (71.6) 0.236 36 (81.8) 40 (80.0) 0.823 Yes 351 (19.7) 272 (25.4) 91 (21.5) 54 (27.4) 8 (18.2) 10 (20.0) Gravidity ≤2 627 (35.2) 360 (33.7) 134 (31.6) 67 (34.0) 0.551 16 (36.4) 14 (28.0) 0.385 ≥3 1,154 (64.8) 709 (66.3) 290 (68.4) 130 (66.0) 28 (63.6) 36 (72.0) Parity ≤2 1,257 (70.6) 725 (67.8) 289 (68.2) 136 (69.0) 0.827 31 (70.5) 38 (76.0) 0.544 ≥3 524 (29.4) 344 (32.2) 135 (31.8) 61 (31.0) 13 (29.5) 12 (24.0) Oral contraceptive No 1,773 (99.6) 1,062 (99.5) 422 (99.5) 196 (99.5) 0.952 43 (97.7) 50 (100.0) 0.284 Yes 8 (0.4) 5 (0.5) 2 (0.5) 1 (0.5) 1 (2.3) 0 (0.0) Menopause No 1,131 (63.5) 655 (61.3) 273 (64.4) 123 (62.4) 0.638 25 (56.8) 31 (62.0) 0.609 Yes 650 (36.5) 414 (38.7) 151 (35.6) 74 (37.6) 19 (43.2) 19 (38.0) - Table 2.
Distribution of histology and presence of E6 oncoprotein in HPV16/18 DNA–positive women (E6 protein/DNA, %)
Normal/CIN1 CIN2/3 SCC/ADC Total HPV16 (E6 protein/DNA, %) 11/75 (14.7) 85/166 (51.2) 335/380 (88.2) 431/621 (69.4) Single HPV16 infections 6/42 (14.3) 51/100 (51.0) 260/282 (92.2) 317/424 (74.8) Multiple HPV16 infections 5/33 (15.2) 34/66 (51.5) 75/98 (76.5) 114/197 (57.9) HPV16 & 18 0/5 (0.0) 0/3 (0.0) 12/20 (60.0) 12/28 (42.9) HPV16 & 52 2/9 (22.2) 7/14 (50.0) 15/16 (93.8) 24/39 (61.5) HPV16 & 59/56/66 0/10 (0.0) 14/21 (66.7) 17/23 (73.9) 31/54 (57.4) HPV16 & 51 1/8 (12.5) 4/5 (80.0) 7/8 (87.5) 12/21 (57.1) HPV16 & 33/58 2/11 (18.2) 8/21 (38.1) 22/28 (78.6) 32/60 (53.3) HPV16 & 39/68/35 1/13 (7.7) 9/15 (60.0) 11/14 (78.6) 21/42 (50.0) HPV16 & 31 0/6 (0.0) 4/7 (57.1) 9/13 (69.2) 13/26 (50.0) HPV16 & 45 0/4 (0.0) 0/2 (0.0) 1/4 (25.0) 1/10 (10.0) HPV18 (E6 protein/DNA, %) 9/26 (34.6) 3/6 (50.0) 49/62 (79.0) 61/94 (64.9) Single HPV18 infections 3/9 (33.3) 1/2(50.0) 31/33 (93.9) 35/44 (79.5) Multiple HPV18 infections 6/17 (35.3) 2/4 (50.0) 18/29 (62.1) 26/50 (52.0) HPV16 & 18 1/5 (20.0) 1/3 (50.0) 10/20 (50.0) 12/28 (42.9) HPV18 & 52 2/2 (100.0) 1/1 (100.0) 1/3 (33.3) 4/6 (66.7) HPV18 & 59/56/66 3/7 (42.9) 0/0 (0.0) 3/5 (60.0) 6/12 (60.0) HPV18 & 31 2/3 (66.7) 0/0 (0.0) 1/2 (50.0) 3/5 (60.0) HPV18 & 39/68/35 1/6 (16.7) 0/0 (0.0) 4/4 (100.0) 5/10 (50.0) HPV18 & 45 0/0 (0.0) 0/0 (0.0) 1/2 (50.0) 1/2 (50.0) HPV18 & 33/58 3/6 (50.0) 0/0 (0.0) 1/3 (33.3) 4/9 (44.4) HPV18 & 51 0/4 (0.0) 0/0 (0.0) 1/2 (50.0) 1/6 (16.7)